Drug Shortage Report for JAMP-SOLIFENACIN

Last updated on 2022-11-09 History
Report ID 160738
Drug Identification Number 02424339
Brand name JAMP-SOLIFENACIN
Common or Proper name Solifenacin Succinate Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) SOLIFENACIN SUCCINATE
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 (bottle)
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-12
Estimated end date 2022-11-10
Actual end date 2022-11-04
Shortage status Resolved
Updated date 2022-11-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v22 2022-11-09 French Compare
v21 2022-11-09 English Compare
v20 2022-10-07 French Compare
v19 2022-10-07 English Compare
v18 2022-10-03 French Compare
v17 2022-10-03 English Compare
v16 2022-09-26 French Compare
v15 2022-09-26 English Compare
v14 2022-09-19 French Compare
v13 2022-09-19 English Compare
v12 2022-09-16 French Compare
v11 2022-09-16 English Compare
v10 2022-09-12 French Compare
v9 2022-09-12 English Compare
v8 2022-08-30 French Compare
v7 2022-08-30 English Compare
v6 2022-08-02 French Compare
v5 2022-08-02 English Compare
v4 2022-06-13 French Compare
v3 2022-06-13 English Compare

Showing 1 to 20 of 22